Pharmaceutical Executive Digital Edition - December 2012
The Puzzle Master
Obamacare, Innovation and Pricing
Tax and budget decisions will shape the healthcare market and drug research and regulation.
2012: Year of Record
The calendar says its wrap-up time, not just for gifts but for some of the trends that shaped the industry-for good or bad-in 2012.
Germany's Price Reform Revolution
At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?
Transforming Drug Development: A Lilly–Covance Case Study
Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.
The Puzzle Master: EMA's Guido Rasi
Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.
Top Medical Innovations for 2013
Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.
Big Data, Bigger Ideas
How to stop worrying and learn to love the data.
